Home LiteratureArticle Details
PMID: 9268374 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Down-regulation of the cyclin A promoter by transforming growth factor-beta1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein.

The Journal of biological chemistry ·Vol. 272 ·No. 35 ·1997-08-29 ·Pages 22259-64

Yoshizumi M, Wang H, Hsieh CM, Sibinga NE, Perrella MA, Lee ME

Abstract

Transforming growth factor (TGF)-beta1 prevents cell cycle progression by inhibiting several regulators, including cyclin A. To study the mechanisms by which TGF-beta1 down-regulates cyclin A gene expression, we transfected reporter plasmids driven by the cyclin A promoter into mink lung epithelial cells in the absence and presence of TGF-beta1. The TGF-beta1-induced down-regulation of cyclin A promoter activity appeared to be mediated via the activating transcription factor (ATF) site, because mutation of this site abolished down-regulation. Surprisingly, although TGF-beta1 treatment for 24 h markedly decreased cyclin A promoter activity, it did not decrease the abundance of the ATF-binding proteins ATF-1 and cyclic AMP-responsive binding protein (CREB). However, we detected 90 and 78% reductions (by Western analysis) in phosphorylated CREB and ATF-1, respectively, in mink lung epithelial cells treated with TGF-beta1. TGF-beta1-induced down-regulation of cyclin A promoter activity was reversed by okadaic acid (a phosphatase inhibitor) and by cotransfection with plasmids expressing the cAMP-dependent protein kinase catalytic subunit or the simian virus small tumor antigen (Sm-t, an inhibitor of PP2A). These data indicate that TGF-beta1 may down-regulate cyclin A promoter activity by decreasing phosphorylation of CREB and ATF-1.

MeSH Terms
Activating Transcription Factor 1 Animals Antigens, Polyomavirus Transforming/metabolism Cells, Cultured Cyclic AMP Response Element-Binding Protein/metabolism Cyclic AMP-Dependent Protein Kinases/metabolism Cyclins/genetics DNA-Binding Proteins Down-Regulation Enzyme Inhibitors/pharmacology Lung/metabolism Mink Okadaic Acid/pharmacology Phosphorylation Promoter Regions, Genetic Transcription Factors/metabolism Transforming Growth Factor beta/pharmacology
Chemicals
Activating Transcription Factor 1 Antigens, Polyomavirus Transforming Cyclic AMP Response Element-Binding Protein Cyclins DNA-Binding Proteins Enzyme Inhibitors Transcription Factors Transforming Growth Factor beta Okadaic Acid Cyclic AMP-Dependent Protein Kinases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Yoshizumi M
Cardiovascular Biology Laboratory, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Wang H
Hsieh C M
Sibinga N E
Perrella M A
Lee M E
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1997-08-29
Pages
22259-64
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NIGMS NIH HHS · GM53249 · United States
NHLBI NIH HHS · HL03194 · United States
NHLBI NIH HHS · HL03274 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com